DOCTEUR VANDENBERGHE
ActiveSummary
DOCTEUR VANDENBERGHE has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €85,883 and a net result of €33,996. Equity has been growing by about 12% per year since 2018. Its solvency ranks better than 59% of 20,736 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 18-10-2006 Normal situation
- Activity
- Medical imaging and medical laboratories NACE 86910and 1 other
- Establishment unit
- 2.241.306.546 7061 Soignies, since 18-10-2006
- Financial year end
- 31 December
- Peppol
- Reachable since 08-02-2026
Board and ownership
- Vandenberghe MarcDirector · since 27-10-2023
- VANDENBERGHE Marc René Eugèneall the sharesdeed of 07-11-2023
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €55,521
- ▼ 18.3%
- Turnover
- ≈ €150,000
- estimated
- Profit
- €33,996
- ▲ 22.2%
- Equity
- €85,883
- ▲ 17.2%
- Total assets
- €119,685
- ▼ 6.8%
- Staff
- ≈ 0.2 FTE
- estimated
- 2025 accounts filed 29 days after the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 3.51, cash €16,175, halvedEquity €85,883 (71.8% of total assets)Founded in 2006Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 60% of them on solvency, 31% on liquidity, 80% on profitability and 61% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 10 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: 8 profitable years in a rowprofit 2025: €33,996 8 years View
Recent changes
- · Gazette deed Change of role: VANDENBERGHE Marc René Eugène, from manager to directorDirector discharge: VANDENBERGHE Marc René Eugène · VANDENBERGHE Marc René Eugène holds all the shares · Legal-form conversion: from private limited company (pre-2019) to private limited company
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as DOCTEUR VANDENBERGHE: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €112,000 and €230,000, founded between 1995 and 2012.
| Company | Total assets | Gross margin |
|---|---|---|
| DOCTEUR VANDENBERGHE Soignies | €119,685 | €55,521 |
| GROEPSPRAKTIJK VIJVE Waregem | €112,274 | €63,475 |
| DR. E. SCHREURS Tremelo | €153,825 | €48,811 |
| DOKTER KOEN PALMERS Alken | €193,996 | €57,854 |
| EP DESIGN Bertem | €146,101 | €107,970 |
| OBIOS Frameries | €230,294 | €36,727 |
| PROF.DR.BEULS Hasselt | €172,741 | €27,266 |
Key facts about DOCTEUR VANDENBERGHE
- What is the company number of DOCTEUR VANDENBERGHE?
- The company number of DOCTEUR VANDENBERGHE is 0884.360.282. The VAT number is the same number with BE in front: BE 0884.360.282.
- Where is DOCTEUR VANDENBERGHE based?
- The registered office is at Rue de Sirieu 117, 7061 Soignies.Company details
- What does DOCTEUR VANDENBERGHE do?
- According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
- What is the legal form of DOCTEUR VANDENBERGHE?
- DOCTEUR VANDENBERGHE is a private limited company (BV).
- When was DOCTEUR VANDENBERGHE founded?
- DOCTEUR VANDENBERGHE was founded on 18-10-2006.
- Is DOCTEUR VANDENBERGHE still active?
- Yes, DOCTEUR VANDENBERGHE is an active enterprise in the KBO register.
- How many employees does DOCTEUR VANDENBERGHE have?
- DOCTEUR VANDENBERGHE had an average of 1 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
- What is the turnover of DOCTEUR VANDENBERGHE?
- The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €55,521 and 33 comparable companies (NACE 869). It probably lies between €100,000 and €230,000. In financial year 2018 turnover was €127,803.
- Is DOCTEUR VANDENBERGHE profitable?
- In financial year 2025, DOCTEUR VANDENBERGHE made a profit of €33,996.
- Where can I find the annual accounts of DOCTEUR VANDENBERGHE?
- DOCTEUR VANDENBERGHE filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DOCTEUR VANDENBERGHE due?
- DOCTEUR VANDENBERGHE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.